Jayne Elizabeth Curry

Title: Jayne Elizabeth Curry: Innovator in Pharmaceutical Combinations

Introduction

Jayne Elizabeth Curry is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative cancer treatments. With a total of 3 patents to her name, her work is recognized for its potential impact on medical science.

Latest Patents

One of her latest patents focuses on pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea. This invention provides combinations of an ancillary compound and a compound which is a salt of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea, selected from the lactate and citrate salts and mixtures thereof. Additionally, it includes crystalline forms of the salts, methods for making the salts, and their uses in treating cancers. Another notable patent involves combinations of pyrazole kinase inhibitors, which comprise a cytotoxic compound, a signaling inhibitor, an ancillary agent, or two or more further anti-cancer agents.

Career Highlights

Jayne is currently associated with Astex Therapeutics Limited, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving cancer treatment options through innovative pharmaceutical solutions.

Collaborations

Throughout her career, Jayne has collaborated with notable colleagues, including John Francis Lyons and Neil Gallagher. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Jayne Elizabeth Curry stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing effective cancer treatments. Her innovative patents and collaborations highlight her dedication to improving healthcare outcomes.